Dopavision is a therapeutic company developing a digital therapeutic for myopia. Founded by Hamed Bahmani and Stefan Zundel in 2017, Dopavision is backed by Boehringer Ingelheim Venture Fund, Seventure Partners, Novartis Pharma, Flyinghealth, and Ralf Meister and is headquartered in Berlin.
FOUNDED:
2017
INDUSTRY:
Biotechnology, Health Care, Medical Device, Therapeutics
FOUNDERS:
Hamed Bahmani, Stefan Zundel
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
